ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical TreatmentHannah Gordon, Tim Raine, Johan Burisch et al.|Journal of Crohn s and Colitis|2024Cited by 338
ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical TreatmentMichel Adamina, Pär Myrelid, Silvia Minozzi et al.|Journal of Crohn s and Colitis|2024Cited by 158
Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn’s Disease in Sustained RemissionCathérine Reenaers, Édouard Louis, Jean–Yves Mary et al.|Clinical Gastroenterology and Hepatology|2017Cited by 92
Efficacy and Safety of Ustekinumab for Chronic Pouchitis: A Prospective Open-label Multicenter StudyAn Outtier, Marc Ferrante, Édouard Louis et al.|Clinical Gastroenterology and Hepatology|2024Cited by 16
Management of immune checkpoint inhibitor in patients with cancer and pre-existing inflammatory bowel disease: Recommendations from the GETAIDAurélien Amiot, Pauline Wils, David Laharie et al.|Digestive and Liver Disease|2022Cited by 12